InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,731.91
(
0.46%
)
US TECH 100
19,532.80
(
0.92%
)
Dow Jones
42,043.70
(
0.67%
)
Brent Oil
73.03
(
-1.33%
)
Bitcoin
69,300.27
(
-1.29%
)
Post# of 253509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

kamehameha

Send PM Follow Ignore
Followers 4
Posts 134
Boards Moderated 0
Alias Born 05/16/2011

kamehameha

Re: oc631 post# 131192

Wednesday, 11/16/2011 11:55:48 AM

Wednesday, November 16, 2011 11:55:48 AM

Post# of 253509

Call or write VRUS IR



did send an email - no response so far

How is running a late-stage oral trial in interferon-intolerant patients any easier than running a trial with treatment-naive patients?



so do you assume that VRUS will only include patients that have been treated and did not tolerate INF?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up